Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · IEX Real-Time Price · USD
43.35
-1.31 (-2.93%)
At close: Mar 28, 2024, 4:00 PM
44.50
+1.15 (2.65%)
After-hours: Mar 28, 2024, 6:09 PM EDT
Ionis Pharmaceuticals Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for IONS stock have an average target of 57.75, with a low estimate of 28 and a high estimate of 88. The average target predicts an increase of 33.22% from the current stock price of 43.35.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IONS stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
Buy | 5 | 4 | 4 | 4 | 4 | 4 |
Hold | 5 | 5 | 6 | 5 | 4 | 4 |
Sell | 1 | 1 | 1 | 1 | 1 | 0 |
Strong Sell | 0 | 1 | 1 | 1 | 1 | 1 |
Total | 13 | 13 | 14 | 14 | 13 | 12 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Oppenheimer | Oppenheimer | Buy Maintains $65 → $72 | Buy | Maintains | $65 → $72 | +66.09% | Mar 6, 2024 |
Oppenheimer | Oppenheimer | Buy Initiates $63 → $65 | Buy | Initiates | $63 → $65 | +49.94% | Feb 26, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $62 → $63 | Buy | Maintains | $62 → $63 | +45.33% | Feb 22, 2024 |
Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +38.41% | Feb 22, 2024 |
JP Morgan | JP Morgan | Hold Maintains $52 → $55 | Hold | Maintains | $52 → $55 | +26.87% | Feb 1, 2024 |
Financial Forecast
Revenue This Year
654.90M
from 787.65M
Decreased by -16.85%
Revenue Next Year
793.93M
from 654.90M
Increased by 21.23%
EPS This Year
-4.08
from -2.56
EPS Next Year
-3.40
from -4.08
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 860.9M | 1.2B | 1.6B | 2.2B | 2.8B |
Avg | 654.9M | 793.9M | 1.1B | 1.4B | 1.8B |
Low | 569.1M | 558.6M | 694.8M | 892.8M | 1.2B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 9.3% | 86.1% | 103.7% | 99.3% | 92.1% |
Avg | -16.9% | 21.2% | 38.3% | 31.1% | 25.6% |
Low | -27.7% | -14.7% | -12.5% | -18.7% | -18.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -3.22 | -0.99 | -0.13 | 1.62 | 3.98 |
Avg | -4.08 | -3.40 | -1.99 | -0.18 | 3.00 |
Low | -5.21 | -5.02 | -4.28 | -3.42 | 1.45 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.